Stock RLMD RELMADA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Relmada Therapeutics, Inc.

Equities

RLMD

US75955J4022

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
3.83 USD +3.51% Intraday chart for Relmada Therapeutics, Inc. -4.25% -7.49%
Mar. 19 Transcript : Relmada Therapeutics, Inc., 2023 Earnings Call, Mar 19, 2024
Mar. 19 Relmada Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Chart calendar Relmada Therapeutics, Inc.

5eb658811d3635a739c8f81.ViZ0Rd6UBTogIa5rC7eNWSupUai3EDY8-JPiU-U52BM.YEQXMpTQQ0ptGeQBSt3UdEiEY_Djf1hfmv6FHqALoGYwUSwskfMwS1FDyQ~14ae1c098cc4ddc5a4f1860ef3c57b04

Upcoming events on Relmada Therapeutics, Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-05-24 09:30 am Annual General Meeting
2024-08-05 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-24 Q4 2024 Earnings Release (Projected)

Past events on Relmada Therapeutics, Inc.

2024-03-19 04:30 pm Q4 2023 Earnings Call
2024-03-19 04:15 pm Q4 2023 Earnings Release
2024-03-10 Leerink Partners Global Biopharma Conference
2023-11-11 08:00 am AASLD Liver Meeting - Abstract Number: 2468-C
2023-11-08 04:30 pm Q3 2023 Earnings Call
2023-11-08 04:01 pm Q3 2023 Earnings Release
2023-10-12 02:30 pm Jefferies Inaugural Biotech CNS/Neuro Summit
2023-10-08 06:35 am European College of Neuropsychopharmacology Congress - Poster No: P.0399
2023-10-08 06:35 am European College of Neuropsychopharmacology Congress - Poster No: P.0166
2023-10-08 06:35 am European College of Neuropsychopharmacology Congress - Poster No: P.0165
2023-08-08 04:30 pm Q2 2023 Earnings Call
2023-08-08 04:01 pm Q2 2023 Earnings Release
2023-06-14 06:20 pm Goldman Sachs Global Healthcare Conference
2023-06-08 03:00 pm Jefferies Global Healthcare Conference
2023-06-01 12:30 pm American Society of Clinical Psychopharmacology Meeting - Poster No T46
2023-05-31 11:15 am American Society of Clinical Psychopharmacology Meeting - Poster No W43
2023-05-25 09:30 am Annual General Meeting
2023-05-11 04:30 pm Q1 2023 Earnings Call
2023-05-11 04:04 pm Q1 2023 Earnings Release
2023-03-23 04:30 pm Q4 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		-60,8
-64,2
5.26%		-85,2
-98,7
13.67%		-161
-152
-6.08%		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-60,8
-59,2
-2.77%		-126
-127
0.87%		-161
-162
0.48%		-104
-103
-0.74%
-115

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-59,5
-56,6
-5.08%		-126
-127
0.6%		-157
-158
0.82%		-98,8
-98,9
0.1%
-111

Net income
Million USD		Released
Forecast
Spread 		-59,5
-56,6
-5.08%		-126
-126
0.56%		-157
-159
0.99%		-98,8
-99,3
0.51%
-112

EPS
USD		Released
Forecast
Spread 		-3,81
-3,56
-7.08%		-7,16
-7,16
-0.02%		-5,30
-5,37
1.3%		-3,28
-3,28
-0.12%
-3,06

Announcement Date23/03/2123/03/2223/03/2319/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-34,2
-33,0
-3.6%		-38,3
-34,1
-12.31%		-45,5
-38,3
-18.94%		-38,7
-44,1
12.08%		-38,7
-39,4
1.67%		-28,2
-34,4
18.16%		-26,0
-28,3
7.99%		-22,7
-28,3
19.72%		-26,8
-25,4
-5.77%
-26,4


-28,0


-29,2


-31,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-34,4
-32,4
-6.24%		-39,7
-33,6
-18.38%		-39,9
-37,7
-5.82%		-39,4
-42,1
6.48%		-37,9
-38,7
1.99%		-26,3
-36,6
27.98%		-25,3
-26,3
3.66%		-22,0
-27,0
18.36%		-25,2
-24,2
-4.2%
-24,7


-25,7


-27,1


-29,5

Net income
Million USD		Released
Forecast
Spread 		-34,4
-32,8
-4.66%		-39,7
-33,8
-17.52%		-39,9
-37,7
-5.84%		-39,4
-43,0
8.41%		-37,9
-39,3
3.36%		-26,3
-28,3
6.83%		-25,3
-26,6
5.05%		-22,0
-28,1
21.7%		-25,2
-25,2
0.14%
-25,6


-26,6


-27,7


-29,8

EPS
USD		Released
Forecast
Spread 		-1,80
-1,83
1.64%		-1,40
-1,27
-10.61%		-1,33
-1,27
-4.49%		-1,31
-1,46
10.48%		-1,26
-1,33
5.41%		-0,87
-0,89
2.25%		-0,84
-0,90
6.32%		-0,73
-0,91
20.13%		-0,84
-0,83
-1.2%
-0,86


-0,91


-0,77


-0,66

Announcement Date23/03/2205/05/2211/08/2210/11/2223/03/2311/05/2308/08/2308/11/2319/03/24----

Upcoming sector events for Relmada Therapeutics, Inc.

2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 04:05 pm EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Relmada Therapeutics, Inc.

2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25 REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 04:05 pm PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RLMD Stock
  4. Calendar Relmada Therapeutics, Inc.